What's Next For Teva Pharmaceutical Following Patent Ruling?
September 02, 2016 at 10:34 AM EDT
On August 24, the Patent Trial and Appeal Board (PTAB) invalidated Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) ‘250 and ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.